Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Energy, mining stocks drag FTSE 100 lower as Amigo tumbles

Published 25/05/2021, 08:29
Updated 25/05/2021, 17:15
© Reuters. FILE PHOTO: A man shelters under an umbrella as he walks past the London Stock Exchange in London, Britain, August 24, 2015. REUTERS/Suzanne Plunkett/File Photo

By Shivani Kumaresan and Devik Jain

(Reuters) -London's FTSE 100 index was dragged lower by energy and mining stocks on Tuesday, while subprime lender Amigo was on track for its worst day on record after a British court rejected its proposed redress scheme.

The blue-chip FTSE 100 index fell 0.3% with oil heavyweights BP (LON:BP) and Royal Dutch Shell (LON:RDSa) falling 1.2% and 1.6% respectively.

Miners including Rio Tinto (LON:RIO), Anglo American (LON:AAL),

Glencore (LON:GLEN) and BHP were also among the biggest drags on the FTSE 100, with shares falling between 1.2% and 1.6%.

However, losses were limited by industrial software company Aveva, which gained 1.6% after saying it was confident about the year ahead as the business environment had improved in most of its major markets.

"The FTSE 100 was struggling for direction ... given the continuing uncertainties over vaccines versus variants, the risks of inflation and the continuing volatility in the commodity and cryptocurrency markets," Russ Mould, investment director at AJ Bell, said.

The domestically focussed mid-cap FTSE 250 index was flat with Royal Mail (LON:RMG) up 6.6% to the top of the index after Peel Hunt upgraded it to "buy" from "hold".

After rising 9% in the first four months of this year on recovery optimism, the FTSE 100 has traded in a tight range in recent sessions on concerns that a resurgence of COVID-19 cases across parts of Asia might delay a global economic recovery.

Amigo's shares tumbled 55.3% after a court refused to sanction a proposed rescue plan to manage its large backlog of redress claims.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among other stocks, AstraZeneca (NASDAQ:AZN) fell 0.8% after Britain's competition regulator said it was reviewing the drugmaker's $39 billion buyout of U.S.-based Alexion (NASDAQ:ALXN).

Latest comments

it's almost like they wanted us to lose on amigo
Amigo news should have been reported much earlier
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.